Anaerobic bacteria colonizing the lower airways in lung cancer patients

Folia Histochemica et Cytobiologica

Volumn 49, Issue 2, 2011, Pages 263-266

  Rybojad, Pawel ^a   Los, Renata ^a   Sawicki, Marek ^a   Tabarkiewicz, Jacek ^a   Malm, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anaerobes; Antimicrobial agent susceptibility; Lower respiratory tract; Lung cancer

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ACTINOMYCES; ADULT; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTEROIDES; BRONCHOSCOPY; BRONCHUS SECRETION; CANCER PATIENT; EGGERTHELLA LENTA; EPSILOMETER TEST; FEMALE; HUMAN; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS JENSENII; LOWER RESPIRATORY TRACT; LUNG CANCER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA; SPECIES DIVERSITY; VEILLONELLA PARVULA; ANAEROBIC GROWTH; BACTERIAL COUNT; BACTERIUM; BRONCHUS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; LUNG TUMOR; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RESPIRATORY SYSTEM;

ACTINOMYCES; BACTEROIDES SP.; EGGERTHELLA LENTA; LACTOBACILLUS JENSENII; PEPTOSTREPTOCOCCUS; PREVOTELLA; VEILLONELLA PARVULA;

ANAEROBIOSIS; ANTI-INFECTIVE AGENTS; BACTERIA; BRONCHI; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RESPIRATORY SYSTEM;

EID: 80055101230     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0036     Document Type: Article

References (22)

1. th ed. Belmont (CA): Star Publishing Co.; 1993.
2. Finegold SM. Anaerobic infection in humans: an overview. Anaerobe. 1995;1:3-9.
3. Durmaz B, Durmaz R, Tastekin N. Evaluation of culture results of specimens from patients with suspected anaerobic infection. New Microbiol. 1999;22:155-159.
4. Marik PE, Careau P. The role of anaerobes in patients with ventilatory-associated pneumonia and aspiration pneumonia. Chest. 1999;115:178-183.
5. Yologlu S, Durmaz B, Bayindir Y. Nosocomial infections and risk factors in intensive care units. New Microbiol. 2003; 26:299-303.
6. Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol. 2004;15:329-335.
7. Putinati S, Trevisani L, Gualandi M et al. Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer. 1994;11:243-249.
8. Duque JL, Ramos G, Castrodeza J. Early complications in surgical treatment of lung cancer: a prospective multicenter study. Ann Thoracic Sur. 1997;63:944-950.
9. Rolston KVI, Bodey GP. Infections in patients with cancer. In: Holland JF, Bast RC Jr, Morton DL, Frei E, Kufe DW, Weichselbaum RR (eds.). Cancer Medicine. Baltimore: Williams and Wilkinson; 1997:3303-3336.
10. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490-494.
11. Doddoli C, Thomas P, Seree Y, Giudicelli R, Fuentes P. Post-operative complications in relation with induction therapy for lung cancer. Eur J Cardiothoracic Surg. 2001;20:385-390.
12. Remiszewski P, Slodowska J, Wiatr E, Zych J, Radomski P, Rowinska-Zakrzewska E. Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994. Lung Cancer. 2001;31:101-110.
13. Berghmans T, Crokaert F, Markiewicz E, Sculier JP. Epidemiology of infections in the adult medical intensive care unit of a cancer hospital. Support Care Cancer. 1997;5: 234-240.
14. Sarihan S, Ercan I, Saran A, Cetintas SK, Akalin H, Engin K. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev. 2005;29:181-188.
15. Bartlett JG. Anaerobic bacterial infections of lung and pleural space. Clin Infect Dis. 1993;16:248-255.
16. Robert R, Grollier G, Dore P, Hira M, Ferrand E, Fauchere JL. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome. J Crit Care. 1999;3:114-119.
17. Drakulovic MB, Bauer TT, Torres A, Gonzalez J, Rodriguez M-J, Angrill J. Initial bacterial colonization in patients admitted to a Respiratory Intensive Care Unit: bacteriological pattern and risk factors. Respiration. 2001;68:58-66.
18. Dubreuil L, Behra-Miellet J, Neut C, Calvet L. In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds. Clin Microbiol Infect. 2003;9:1133-1138.
19. Brook J. Management of anaerobic. Expert Rev Anti-infect Ther. 2004;2:153-158.
20. Aldridge KE, Ashcraft D, Cambre K, Pierson L, Jenkins SD, Rosenblatt JE. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicorb Agents Chemother. 2001;4:1238-1243.
21. Fang H, Edlund C, Hedberg M, Nord CE. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group. Int J Antimicrob Agents. 2002;19:361-370.
22. Liu CY, Huang YT, Liao CH, Yen LC, Lin HY, Hsueh PR. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicorb Agents Chemother. 2008;52:3161-3168.